MNMohsen Nazari

Mohsen Nazari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohsen Nazari has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Amjad Ahmadi

    Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran

    2 shared publications
  • Ali Bahrami

    Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Science, Hamadan, Iran

    1 shared publication
  • Babak Asghari

    Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

    1 shared publication
  • Faezeh Jahanian

    Department of Microbiology, Hamedan Branch, Islamic Azad University, Hamedan, Iran

    1 shared publication
  • Jaber Hemmati

    Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

    1 shared publication
  • Jaber Hemmati

    Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

    1 shared publication

Latest Publications

  • Innovative Non-antibiotic Strategies for Combating Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections

    by Mohsen Nazari, Ali Bahrami, Faezeh Jahanian

    Diabetic foot infections (DFIs) are a common and serious complication of diabetes mellitus (DM), often caused by methicillin-resistant Staphylococcus aureus (MRSA), which is challenging to treat due to its antibiotic resistance. The ability of MRSA to form biofilms and its resistance to commonly used antibiotics, such as beta-lactams, clindamycin, and trimethoprim–sulfamethoxazole, complicate treatment strategies. The pathophysiology of MRSA in DFIs involves bacterial virulence factors, including adhesion proteins, exotoxins, and immune evasion mechanisms, which allow MRSA to persist in infected wounds despite compromised immune responses in diabetic patients. Diabetes-related conditions such as neuropathy, poor glycemic control, and ischemia further exacerbate the susceptibility to and severity of these infections. With conventional antibiotic therapies facing increasing resistance, alternative non-antibiotic treatment options, including antimicrobial peptides, bacteriophage therapy, and nanotechnology-based interventions, are emerging as promising strategies. This review evaluates these alternative approaches, examining their potential to improve patient outcomes and combat antibiotic-resistant MRSA in DFIs.


  • Open Access

    Comparison of Common Bacteria That Cause Meningitis in Cerebrospinal Fluid Samples by Culture and Polymerase Chain Reaction

    by Amjad Ahmadi, Mohammad Sina Alikhani, Mohsen Nazari, Jaber Hemmati, Rasoul Yousefimashouf, Seyyed Hamid Hashemi, Mohammad Yousef Alikhani

    Background: The etiology of meningitis, an infection and inflammation of the meningeal membranes surrounding the brain and spinal cord, is multifactorial. Among the infectious etiologies are viruses, bacteria, parasites, and fungi. Objectives: The objective of this study is to utilize the molecular polymerase chain reaction (PCR) method to detect bacterial infections causing meningitis in cerebrospinal fluid (CSF) samples from hospitalized patients suspected of having meningitis. Subsequently, a comparison is made between the PCR results and the results of sample cultures obtained in the laboratories of Hamadan educational hospitals. Methods: This study was conducted on 104 CSF samples collected from hospitalized patients suspected of having meningitis at the educational hospitals of Hamadan University of Medical Sciences from February 2022 to August 2023. The most common etiological agents of bacterial meningitis were identified using culture and PCR methods. These included Escherichia coli K1, Listeria monocytogenes, Streptococcus agalactiae, Neisseria meningitidis, S. pneumoniae, and Haemophilus influenzae. Results: The mean age of the patients in this study was 31.57 ± 25.85 years. Of the participants, 53.85% were male and 46.15% were female. No bacteria were isolated from the studied samples by culture in hospital laboratories. However, the PCR method yielded the identification of five (4.81%) bacterial cases, including L. monocytogenes (0.96%), S. pneumoniae (1.92%), and S. agalactiae (1.92%), in the CSF samples under investigation. Conclusions: The findings of this study indicated a low prevalence of common bacterial infections in CSF samples. Furthermore, the study demonstrated that the molecular method is more precise and sensitive in detecting these bacteria compared to traditional culture techniques.


  • Open Access

    Enhancing antibiotic therapy through comprehensive pharmacokinetic/pharmacodynamic principles

    by Mohammad Sina Alikhani, Mohsen Nazari, Shima Hatamkhani

    Antibiotic therapy relies on understanding both pharmacokinetics (PK) and pharmacodynamics (PD), which respectively address drug absorption, distribution, and elimination, and the relationship between drug concentration and antimicrobial efficacy. This review synthesizes decades of research, drawing from in-vitro studies, in-vivo models, and clinical observations, to elucidate the temporal dynamics of antibiotic activity. We explore how these dynamics, including concentration-effect relationships and post antibiotic effects, inform the classification of antibiotics based on their PD profiles. Additionally, we discuss the pivotal role of PK/PD principles in determining optimal dosage regimens. By providing a comprehensive overview of PK/PD principles in antibiotic therapy, this review aims to enhance understanding and improve treatment outcomes in clinical practice.


  • Open Access

    Natural products in the treatment of diabetic foot infection

    by Mohsen Nazari, Leili Shokoohizadeh, Mohammad Taheri

    Diabetic foot infections (DFIs) are a significant complication in diabetes mellitus, leading to increased morbidity, hospitalizations, and healthcare burdens. The growing prevalence of antibiotic-resistant pathogens has reduced the efficacy of conventional treatments, highlighting the need for alternative therapeutic strategies. Natural products, known for their antimicrobial, anti-inflammatory, and wound-healing properties, have garnered attention as potential treatments for DFIs. This review examines key natural compounds, including eugenol, thymol, carvacrol, curcumin, and Aloe vera, and their mechanisms of action in combating diabetic infections. We analyze the antimicrobial efficacy of these compounds, their ability to inhibit biofilm formation, and their role in wound healing. The review also explores challenges in integrating natural products into clinical practice and the potential for their use alongside or in place of traditional antibiotic therapies. Our findings suggest that natural products could play a crucial role in developing sustainable and effective treatment strategies for DFIs, especially in the face of rising antimicrobial resistance.


  • Open Access

    Comprehensive Analysis of Virulence Genes, Antibiotic Resistance, Biofilm Formation, and Sequence Types in Clinical Isolates of Klebsiella pneumoniae

    by Mohsen Nazari, Jaber Hemmati, Babak Asghari

    Background: The rise in multidrug‐resistant pathogens poses a formidable challenge in treating hospital‐acquired infections, particularly those caused by Klebsiella pneumoniae. Biofilm formation is a critical factor contributing to antibiotic resistance, enhancing bacterial adherence and persistence. K. pneumoniae strains vary in virulence factors, influencing their pathogenicity and resistance profiles. This study aimed to comprehensively analyze virulence factors, antibiotic resistance patterns, and biofilm formation in clinical isolates of K. pneumoniae from Hamadan hospitals. Moreover, the study explored the molecular epidemiological relationships among isolates using multilocus sequence typing (MLST) to uncover the genetic diversity associated with resistance and virulence.Materials and Methods: Between December 2022 and April 2024, 402 K. pneumoniae isolates were collected from clinical samples, including urine, tracheal aspirates, blood, wounds, and abscesses, in teaching hospitals in Hamadan. Initial culturing was performed on blood agar and MacConkey agar, and isolates were identified using biochemical tests. Antimicrobial susceptibility testing followed CLSI, employing the Kirby–Bauer disk diffusion method with 10 antibiotics. Biofilm formation was assessed using the microtiter plate method, and virulence genes were detected by PCR. MLST analysis was conducted on 10 selected isolates based on their virulence gene profiles and resistance patterns.Result: Of the 456 clinical isolates analyzed, 402 (88.15%) were identified as K. pneumoniae, predominantly isolated from tracheal samples (251/402, 62.44%), followed by urine (105/402, 26.12%), blood (30/402, 7.46%), wounds (15/402, 3.73%), and abscesses (1/402, 0.25%). Antibiotic resistance rates revealed high resistance to cefepime (356/402, 88.55%), imipenem (345/402, 85.82%), and ceftazidime (305/402, 75.87%), while resistance to amikacin (165/402, 41.04%) and piperacillin–tazobactam (75/402, 18.65%) was comparatively lower. Biofilm formation varied among the isolates, with 17/402 (4.22%) forming strong biofilms, 104/402 (25.87%) moderate biofilms, 180/402 (44.78%) weak biofilms, and 101/402 (25.12%) showing no biofilm production. Virulence gene analysis indicated high prevalence rates for mrkD (396/402, 98.50%), fimH1 (351/402, 87.31%), and entB (402/402, 100%), while genes like irp-1 (151/402, 37.56%) and irp-2 (136/402, 33.83%) were less common, and hylA and cnf-1 were absent. MLST analysis of 10 selected isolates identified sequence types ST147 (5/10, 50%), ST11 (3/10, 30%), and ST15 (2/10, 20%).Conclusion: K. pneumoniae demonstrates notable biofilm‐associated antibiotic resistance, supported by a significant association with XDR strains, along with a diverse array of virulence gene profiles. The study underscores the importance of understanding molecular epidemiology for effective management of hospital infections, emphasizing the need for targeted surveillance and infection control measures.